홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Pyridine → HCID 5275155, 화합물

HRID 1988807
노트
인쇄 미리보기

반응식

HRID 1988807 반응식
[C:1]1([N:11]2[CH:15]=[N:14][NH:13][C:12]2=[S:16])[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[CH:4]=[CH:3][CH:2]=1.Br[CH2:18][C:19]([NH:21][C:22]1[CH:27]=[CH:26][CH:25]=[CH:24][C:23]=1[N+:28]([O-:30])=[O:29])=[O:20].N1C=CC=CC=1>CS(C)=O.O>[C:1]1([N:11]2[CH:15]=[N:14][N:13]=[C:12]2[S:16][CH2:18][C:19]([NH:21][C:22]2[CH:27]=[CH:26][CH:25]=[CH:24][C:23]=2[N+:28]([O-:30])=[O:29])=[O:20])[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[CH:4]=[CH:3][CH:2]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 3

HCID 1049PyridineHCID 2207872-Bromo-n-(2-nitrophenyl)acetamideHCID 28887991HCID 28887991, 화합물

생성물 1

HCID 5275155HCID 5275155, 화합물수율 2.2%

시약·촉매·용매 2

HCID 679Dimethyl Sulfoxide용매2회HCID 962Water용매

실험 절차

A solution of 2,4-dihydro-4-(1-naphthalenyl)-3H-1,2,4-triazole-3-thione (129 mg, 0.50 mmol) in DMSO (2 mL) was added slowly to a solution of 2-bromo-N-(2-nitrophenyl)acetamide (113 mg, 0.50 mmol) and pyridine (121 μL, 1.49 mmol) in DMSO (1 mL) at room temperature. The mixture was stirred at room temperature for 18 h, then diluted with water and extracted with EtOAc (50 mL). The organic layer was washed with water (3×) and brine, dried (MgSO4), filtered and concentrated under reduced pressure. A mixture of Et2O and hexane (1:1) was added, the resulting suspension was filtered and the filtrate was concentrated under reduced pressure. The residue was purified by HPLC using a gradient of MeCN/H2O containing TFA (0.06%) (CombiPrep ODS-AQ 50×20 mm, 5μ, 120 Å). The pure fractions were combined and concentrated to give the title compound (4.5 mg, 2% yield).

후처리

  1. extractionextracted with EtOAc (50 mL)
  2. washThe organic layer was washed with water (3×) and brine
  3. dry with materialdried (MgSO4)
  4. filtrationfiltered
  5. concentrationconcentrated under reduced pressure
  6. additionA mixture of Et2O and hexane (1:1)
  7. additionwas added
  8. filtrationthe resulting suspension was filtered
  9. concentrationthe filtrate was concentrated under reduced pressure
  10. customThe residue was purified by HPLC
  11. additioncontaining TFA (0.06%) (CombiPrep ODS-AQ 50×20 mm, 5μ, 120 Å)
  12. concentrationconcentrated

출처 및 근거

ORD 기록
ord-3de7a3f32d4c4aca8d9eab505dd60f75
출처 데이터셋
uspto-grants-2010_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07642277B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트